Pelvis

• A Los Angeles County Superior Court jury in Van Nuys has awarded $11,045,000 to a motorcyclist who suffered serious injuries following a collision with a Los Angeles Department of Water and Power (DWP) vehicle.
• Plaintiff was represented at trial by Robert Glassman, Tom Schultz, and Jonathan Davidi of Panish | Shea | Ravipudi LLP .
• "The City of Los Angeles Department of Water and Power fought us every step of the way," said Robert Glassman, partner at Panish | Shea | Ravipudi LLP.
• We are thankful the jury got it right and delivered a just verdict based on the evidence and their common sense."

• La Ciotat, FRANCE, March 26, 2024 /PRNewswire/ -- Medical imaging AI company Avicenna.AI today announced that it has received 510(k) clearance from the US Food and Drug Administration for its CINA-iPE and CINA-ASPECTS products.
• Using a combination of deep learning and machine learning technologies, the company develops AI solutions that automatically detect and prioritize life-threatening conditions within seconds, assess them for severity, and seamlessly notify clinicians.
• CINA-iPE and CINA-ASPECTS are the latest tools from Avicenna.AI to secure FDA clearance, joining its AI solutions for medical emergencies, including automatic detection of intracranial hemorrhage (CINA-ICH), large vessel occlusion (CINA-LVO), aortic dissection (CINA-AD), pulmonary embolism (CINA-PE) from CT-scan imaging.
• "The clearance of CINA-iPE and CINA-ASPECTS marks a significant milestone in our mission to strive for excellence in advancing patient care.

• CurvaFix, Inc ., a developer of medical devices that deliver stable fixation for curved anatomy and poor bone quality, announced today the appointment of J. Kurt Jacobus, Ph.D., as the newest member of its Board of Directors.
• “We are delighted to welcome Kurt to CurvaFix’s Board of Directors,” said Mark Foster, CEO at CurvaFix.
• “His extensive experience and proven track record of success in the orthopedic medical device sector makes him an invaluable addition to our board.
• “I am honored to join CurvaFix’s excellent Board of Directors,” said Dr. Jacobus.

• Proton beam therapy is a more precise treatment that can better focus radiation on a cancer, reducing the side-effects of treatment.
• This leads to better cognitive function and fewer long-term side-effects among patients who receive proton therapy compared to X-ray (photon) treatment.
• Although proton therapy is more expensive to deliver than photon radiation, studies have shown long-term cost-effectiveness of proton beam therapy for medulloblastoma.
• In a study of more than 1,000 adults with other types of locally advanced cancer, proton therapy led to fewer unplanned hospitalizations.

Canadian patients need to travel for treatment

• Researchers in the U.K. estimate that up to 15 per cent of all patients with curable cancers may benefit from proton therapy.
• However, without a domestic facility, Canadians who need proton beam therapy must travel out-of-country to receive this medically necessary treatment for their cancer.

Patients who are able to travel out-of-country report high levels of stress and feelings of isolation. Many of these concerns would be reduced with a domestic, Canadian proton therapy facility.

Progress toward Canadian facilities

In 2016, Québec announced a partnership with a private health-care company to build a standalone proton therapy facility in Montréal.

• It is recognized that the per-patient cost to deliver proton therapy would be less if a Canadian facility were available.
• Canadian doctors and patients eagerly await the day when a cancer patient can receive this advanced treatment without travelling out of country.
• Having access to proton therapy would also allow Canadian researchers to collaborate globally in scientific studies.

Derek Tsang receives research grant funding from ACCESS (https://accessforkidscancer.ca), the Brain Tumour Foundation of Canada, and the US National Cancer Institute. Tsang also received travel funding from Mevion Medical Systems in 2022.